| # | Drug | Count |
|---|---|---|
| 0 | DENOSUMAB | 33461 |
| 1 | PREDNISONE | 16026 |
| 2 | METHOTREXATE SODIUM | 13531 |
| 3 | ETANERCEPT | 13346 |
| 4 | METHOTREXATE | 12332 |
| 5 | INFLIXIMAB | 12036 |
| 6 | ERGOCALCIFEROL | 9276 |
| 7 | ACETAMINOPHEN | 9211 |
| 8 | RISPERIDONE | 8834 |
| 9 | RITUXIMAB | 8605 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | IVOSIDENIB | 291 | 0.4261 |
| 1 | INFLIXIMAB-DYYB | 3130 | 0.4030 |
| 2 | ISAVUCONAZONIUM SULFATE | 593 | 0.3611 |
| 3 | BECAPLERMIN | 664 | 0.3182 |
| 4 | CARGLUMIC ACID | 108 | 0.3077 |
| 5 | PURIXAN | 134 | 0.2932 |
| 6 | RITUXIMAB-ABBS | 253 | 0.2630 |
| 7 | IVABRADINE | 866 | 0.2449 |
| 8 | DEFIBROTIDE SODIUM | 435 | 0.2442 |
| 9 | IBUPROFEN AND FAMOTIDINE | 287 | 0.2390 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 37291 |
| 1 | RANK Ligand Inhibitor [EPC] | 33461 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 29427 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 21926 |
| 4 | Atypical Antipsychotic [EPC] | 17033 |
| 5 | Kinase Inhibitor [EPC] | 15327 |
| 6 | Benzodiazepine [EPC] | 14728 |
| 7 | Anti-epileptic Agent [EPC] | 13954 |
| 8 | Platelet Aggregation Inhibitor [EPC] | 12657 |
| 9 | Folate Analog Metabolic Inhibitor [EPC] | 12300 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Human Platelet-derived Growth Factor [EPC] | 664 | 0.3182 |
| 1 | Carbamoyl Phosphate Synthetase 1 Activator [EPC] | 108 | 0.3077 |
| 2 | Interleukin-1 Receptor Antagonist [EPC] | 1958 | 0.2270 |
| 3 | RANK Ligand Inhibitor [EPC] | 33461 | 0.2261 |
| 4 | Lipoglycopeptide Antibacterial [EPC] | 148 | 0.2161 |
| 5 | Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] | 122 | 0.2037 |
| 6 | Growth Hormone Secretagogue Receptor Agonist [EPC] | 1 | 0.2000 |
| 7 | Catecholamine Synthesis Inhibitor [EPC] | 5 | 0.1852 |
| 8 | Estrogen Agonist/Antagonist [EPC] | 449 | 0.1814 |
| 9 | Lead Chelator [EPC] | 7 | 0.1750 |